[1]王湘 李刚 王水云.合并巨大左心室的心脏瓣膜病治疗现状[J].心血管病学进展,2024,(9):769.[doi:10.16806/j.cnki.issn.1004-3934.2024.09.001]
　WANG Xiang,L I Gang,WANG Shuiyun.Treatment Status of Valvular Heart Disease with Giant Left Ventricle[J].Advances in Cardiovascular Diseases,2024,(9):769.[doi:10.16806/j.cnki.issn.1004-3934.2024.09.001]
点击复制

合并巨大左心室的心脏瓣膜病治疗现状()
分享到：

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2024年9期
页码:
769
栏目:
综述
出版日期:
2024-09-25

文章信息/Info

Title:
Treatment Status of Valvular Heart Disease with Giant Left Ventricle
作者:
王湘 李刚 王水云
(中国医学科学院阜外医院深圳医院心脏大血管外科,广东 深圳 518000)
Author(s):
WANG Xiang; L I Gang; WANG Shuiyun
(Department of Cardiac and Large Vascular Surgery,Fuwai Shenzhen Hospital,Chinese Academy of Medical Sciences,Shenzhen 58000,Guangdong,China)
关键词:
巨大左心室;  主动脉瓣反流; 二尖瓣反流; 危重心脏瓣膜病; 介入瓣膜
Keywords:
Giant left ventricle;  Aortic regurgitation; Mitral regurgitation; Critical valvular heart disease; Interventional valve
DOI:
10.16806/j.cnki.issn.1004-3934.2024.09.001
摘要:
合并巨大 左心室的心脏瓣膜病往往伴随着心功能不全，是手术治疗的重要危险因素之一。了解巨大左心室的评估以及相关病理生理改变，对把握患者的手术时机、改善患者长期预后至关重要。随着心肌保护、术中监测措施、人工瓣膜设计等综合因素的不断进步，常规瓣膜置换术仍是主要的手术方式并取得满意的效果，但近年来介入瓣膜植入技术取得快速发展，很可能为合并巨大左心室的心脏瓣膜病患者提供一种更安全的手术方式选择。
Abstract:
Valvular heart disease with giant left ventricle is often accompanied by cardiac insufficiency,which is one of the important risk factors for surgical treatment. Understanding the evaluation of giant left ventricle and related pathophysiological changes is very important for grasping the timing of surgery and improving the long-term prognosis of patients. At the same time,with the continuous progress of myocardial protection,intraoperative monitoring measures,prosthetic valve design and other comprehensive factors,the conventional valve replacement is still the main surgical method and has achieved satisfactory results. The rapid development of interventional valve implantation technology in recent years is likely to provide a safer surgical option for patients with valvular heart disease and giant left ventricle

参考文献/References:

[1] 朱家麟. 关于危重心脏瓣膜病标准的探讨[J]. 中华外科杂志,1994,32(6):323-324.

[2] Lang RM,Bierig M,Devereux RB,et al. Recommendations for chamber quantification:a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group,developed in conjunction with the European Association of Echocardiography,a branch of the European Society of Cardiology[J]. J Am Soc Echocardiogr,2005,18(12):1440-1463.

[3] Fukunaga N,Ribeiro RVP,Lafreniere-Roula M,et al. Left ventricular size and outcomes in patients with left ventricular ejection fraction less than 20[J]. Ann Thorac Surg,2020,110(3):863-869.

[4] 尚亮,姜胜利,任崇雷,等. 二尖瓣关闭不全合并巨大左心室外科治疗效果[J]. 中国体外循环杂志,2015,13(1):29-32,56.

[5] Han D,Zhang Y,Xue DM,et al. Valve replacement for valvular heart disease with giant left ventricle[J]. Eur Rev Med Pharmacol Sci,2015,19(16):3001-3005.

[6] 龚达,李温斌,陈宝田,等. 二尖瓣关闭不全合并巨大左心室外科治疗及远期随访[J]. 心肺血管病杂志,2014,33(1):21-24.

[7] Kim HM,Cho GY,Hwang IC,et al. Myocardial strain in prediction of outcomes after surgery for severe mitral regurgitation[J]. JACC Cardiovasc Imaging,2018,11(9):1235-1244.

[8] Hiemstra YL,Tomsic A,van Wijngaarden SE,et al. Prognostic value of global longitudinal strain and etiology after surgery for primary mitral regurgitation[J]. JACC Cardiovasc Imaging,2020,13(2 Pt 2):577-585.

[9] Lee JC,Branch KR,Hamilton-Craig C,et al. Evaluation of aortic regurgitation with cardiac magnetic resonance imaging:a systematic review[J]. Heart,2018,104(2):103-110.

更新日期/Last Update: 2024-10-16